AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

OncLive® Presents State of the Science Summit™ on the Treatment of Hematologic Malignancies

September 10, 2019 GMT

CRANBURY, N.J.--(BUSINESS WIRE)--Sep 10, 2019--

OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to offer the best patient care, will host its latest State of the Science Summit™ on the Treatment of Hematologic Malignancies on Tuesday, Sept. 24, from 5 to 9 p.m. at the Sofitel Philadelphia in Pennsylvania. The summit will be chaired by Edward A. Stadtmauer, M.D., physician; section chief, hematologic malignancies; Roseman, Tarte, Harrow, and Shaffer Families’ president’s distinguished professor; Abramson Cancer Center, University of Pennsylvania.

ADVERTISEMENT

This interactive and educational meeting will analyze novel treatments for patients with hematologic malignancies. Expert presenters will discuss topics facing hematologic malignancies specialists, oncologists, nurses and other medical professionals, such as Hodgkin and non-Hodgkin lymphoma, the treatment landscape of multiple myeloma treatments for mantle cell lymphoma and acute myeloid leukemia, and treatment options for patients with chronic myeloid leukemia and benign hematologic disorders. The summit will also explore the latest updates in CAR-T, such as acute lymphoblastic leukemia, diffuse large B-cell lymphoma and chronic lymphocytic leukemia. The presenters will also engage in a peer exchange and address audience questions.

Presenters for the summit will include the following physician experts from the Abramson Cancer Center:

  • Daria V. Babushok, M.D., Ph.D., assistant professor of pediatrics and medicine.
  • Noelle Frey, M.D., M.S., director, clinical cellular therapy, cell and transplant therapy program; associate professor of medicine.
  • James Gerson, M.D., assistant professor of clinical medicine.
  • Sunita Nasta, M.D., chair, clinical trials review monitoring committee; associate professor of clinical medicine.
  • Alexander Edward Perl, M.D., M.S., associate professor of medicine.
  • Jakub Svoboda, M.D., assistant professor of medicine.
  • Adam Waxman, M.D., assistant professor of clinical medicine.

State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.

Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit https://www.onclive.com/meetings/soss or contact Kayla Collins at kcollins@onclive.com.

About OncLive®

ADVERTISEMENT

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive® is a brand of MJH Life Sciences ™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190910005714/en/

CONTACT: OncLive® Media Contacts

John Patricolo, 609-325-4630

jpatricolo@mjhassoc.com

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: SURGERY HEALTH HOSPITALS ONCOLOGY

SOURCE: OncLive®

Copyright Business Wire 2019.

PUB: 09/10/2019 09:51 AM/DISC: 09/10/2019 09:51 AM

http://www.businesswire.com/news/home/20190910005714/en

ADVERTISEMENT